Drug Type Small molecule drug |
Synonyms CAT-4000 series |
Target |
Mechanism NF-κB inhibitors(Nuclear factor NF-kappa-B complex inhibitors), Nrf2 stimulants(Nuclear factor erythroid 2-related factor 2 stimulants) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Friedreich Ataxia | Discovery | US | - | |
Inflammation | Discovery | US | - | |
Motor Neuron Disease | Discovery | US | - | |
Multiple Sclerosis | Discovery | US | - | |
Psoriasis | Discovery | US | - |